Christian Sebastian Michel

Attending physician, Head of Myeloma Service

University Medical Center of the Johannes Gutenberg University Mainz

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Christian Sebastian Michel is an Attending Physician and Head of Myeloma Service at the University Medical Center of the Johannes Gutenberg University Mainz, Germany. His current research focuses on multiple myeloma, exploring topics such as risk stratification, CAR-T therapy, and treatment outcomes for newly diagnosed and relapsed patients. He has contributed significantly to the understanding of therapeutic approaches and biomarkers in the management of hematological malignancies.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2020

Collaborators (1)

Sebastian Grosicki

Head of Department, MD PhD, Ass. Prof.

Medical University of Silesia

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christian Sebastian Michel

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial

Bridging intensity is associated with impaired hematopoietic recovery following BCMA CAR-T therapy for multiple myeloma

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

A German multicenter real‐world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma

Effective treatment of refractory monoclonal gammopathy‐associated pure red cell aplasia with isatuximab, pomalidomide and dexamethasone

EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma

Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

Loss of SUV420H2-Dependent Chromatin Compaction Drives Right-Sided Colon Cancer Progression

Comparative transcriptional profiling of regenerating damaged knee joints in two animal models of the newt Notophthalmus viridescens strengthens the role of candidate genes involved in osteoarthritis

ERK3/MAPK6 controls IL-8 production and chemotaxis

Collaborators (1)

Sebastian Grosicki

Make your next move.